These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The role of lead in gout nephropathy. Batuman V; Maesaka JK; Haddad B; Tepper E; Landy E; Wedeen RP N Engl J Med; 1981 Feb; 304(9):520-3. PubMed ID: 6779160 [No Abstract] [Full Text] [Related]
6. Moonshine and lead. Relationship to the pathogenesis of hyperuricemia in gout. Reynolds PP; Knapp MJ; Baraf HS; Holmes EW Arthritis Rheum; 1983 Sep; 26(9):1057-64. PubMed ID: 6412722 [No Abstract] [Full Text] [Related]
7. Experimental hyperuricemia in rats. Bluestone R; Klinenberg JR; Waisman J; Goldberg LS Adv Exp Med Biol; 1974; 41():551-4. PubMed ID: 4832581 [No Abstract] [Full Text] [Related]
8. Origin and extrarenal elimination of uric acid in man. Sorensen LB; Levinson DJ Nephron; 1975; 14(1):7-20. PubMed ID: 1124137 [TBL] [Abstract][Full Text] [Related]
9. [Diet therapy for management of hyperuricemia and gout]. Iwatani M Nihon Rinsho; 2003 Jan; 61 Suppl 1():184-92. PubMed ID: 12629715 [No Abstract] [Full Text] [Related]
10. Triglyceride concentrations in primary gout and gout of chronic lead nephropathy. Emmerson BT; Knowles BR Metabolism; 1971 Aug; 20(8):721-9. PubMed ID: 5568414 [No Abstract] [Full Text] [Related]
11. [Gout and hyperuricemia associated with lead poisoning]. Lejeune E; Tolot F; Meunier P Rev Rhum Mal Osteoartic; 1969 Apr; 36(4):161-73. PubMed ID: 5402943 [No Abstract] [Full Text] [Related]
12. The pathogenesis of hyperuricemia and gout in sickle cell anemia. Ball GV; Sorensen LB Arthritis Rheum; 1970; 13(6):846-8. PubMed ID: 4924596 [No Abstract] [Full Text] [Related]
13. Lead nephropathy and gout. Yu TF Am J Kidney Dis; 1983 Mar; 2(5):555-8. PubMed ID: 6829572 [No Abstract] [Full Text] [Related]
14. Diminished renal urate secretion per nephron as a basis for primary gout. Rieselbach RE; Sorensen LB; Shelp WD; Steele TH Ann Intern Med; 1970 Sep; 73(3):359-66. PubMed ID: 4917177 [No Abstract] [Full Text] [Related]
15. Pathogenesis of gout. Choi HK; Mount DB; Reginato AM; ; Ann Intern Med; 2005 Oct; 143(7):499-516. PubMed ID: 16204163 [No Abstract] [Full Text] [Related]
16. Effect of low level lead exposure on hyperuricemia and gout among middle aged and elderly men: the normative aging study. Shadick NA; Kim R; Weiss S; Liang MH; Sparrow D; Hu H J Rheumatol; 2000 Jul; 27(7):1708-12. PubMed ID: 10914856 [TBL] [Abstract][Full Text] [Related]
17. [Physiopathology and treatment of hyperuricemia and gout]. Louyot P; Pourel J; Gaucher A; Montet Y Rein Foie; 1971; 13():103-27. PubMed ID: 5147550 [No Abstract] [Full Text] [Related]
19. [Current aspects of pathogenesis of hyperuricemia and podagra]. Astapenko MG; Dzhen-gu K Ter Arkh; 1979; 51(12):106-11. PubMed ID: 395711 [No Abstract] [Full Text] [Related]
20. Patients with gout differ from healthy subjects in renal response to changes in serum uric acid. Liu S; Perez-Ruiz F; Miner JN Joint Bone Spine; 2017 Mar; 84(2):183-188. PubMed ID: 27324603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]